Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study.

Screening for inherited thrombophilia (IT) is controversial; persons at high risk for venous thromboembolism (VTE) who benefit from screening need to be identified. We tested 533 first- and second-degree relatives of 206 pediatric VTE patients for IT (antithrombin, protein C, protein S, factor V G1691A, factor II G20210A) and determined the incidence of symptomatic VTE relative to their IT status. The risk for VTE was significantly increased among family members with, versus without, IT (hazard ratio = 7.6; 95% confidence interval [CI], 4.0-14.5; P < .001) and highest among carriers of antithrombin, protein C, or protein S deficiency (hazard ratio = 25.7; 95% CI, 12.2-54.2; P < .001). Annual incidences of VTE were 2.82% (95% CI, 1.63%-4.80%) among family members found to be carriers of antithrombin, protein C, or protein S deficiency, 0.42% (0.12%-0.53%) for factor II G202010A, 0.25% (0.12%-0.53%) for factor V G1691A, and 0.10% (0.06%-0.17%) in relatives with no IT. Given the high absolute risk of VTE in relatives with protein C, protein S, and antithrombin deficiency, we suggest screening for these forms of hereditary thrombophilia in children with VTE and their relatives. Interventional studies are required to assess whether thromboembolism can be prevented in this high-risk population.
AuthorsSusanne Holzhauer, Neil A Goldenberg, Ralf Junker, Christine Heller, Monika Stoll, Daniela Manner, Rolf Mesters, Anne Krümpel, Michael Stach, Ulrike Nowak-Göttl
JournalBlood (Blood) Vol. 120 Issue 7 Pg. 1510-5 (Aug 16 2012) ISSN: 1528-0020 [Electronic] United States
PMID22581447 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
  • Aging (pathology)
  • Child
  • Disease-Free Survival
  • Female
  • Germany (epidemiology)
  • Heterozygote
  • Humans
  • Incidence
  • Male
  • Risk Factors
  • Thrombophilia (complications, epidemiology)
  • Venous Thromboembolism (complications, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: